Freeline Therapeutics Holdings PLC
NASDAQ:FRLN
Income Statement
Earnings Waterfall
Freeline Therapeutics Holdings PLC
Revenue
|
625k
USD
|
Operating Expenses
|
-67.8m
USD
|
Operating Income
|
-67.2m
USD
|
Other Expenses
|
17.2m
USD
|
Net Income
|
-49.9m
USD
|
Income Statement
Freeline Therapeutics Holdings PLC
Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
+1%
|
|
Operating Income | |||||||||
Operating Expenses |
(140)
|
(137)
|
(125)
|
(113)
|
(97)
|
(88)
|
(79)
|
(68)
|
|
Selling, General & Administrative |
(45)
|
(46)
|
(46)
|
(43)
|
(42)
|
(39)
|
(35)
|
(32)
|
|
Research & Development |
(95)
|
(88)
|
(77)
|
(68)
|
(55)
|
(49)
|
(44)
|
(35)
|
|
Other Operating Expenses |
0
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
|
Operating Income |
(140)
N/A
|
(137)
+2%
|
(125)
+9%
|
(113)
+9%
|
(97)
+14%
|
(88)
+10%
|
(78)
+10%
|
(67)
+14%
|
|
Pre-Tax Income | |||||||||
Interest Income Expense |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
Non-Reccuring Items |
(2)
|
0
|
0
|
0
|
(2)
|
18
|
20
|
20
|
|
Total Other Income |
2
|
4
|
8
|
12
|
9
|
9
|
6
|
(2)
|
|
Pre-Tax Income |
(140)
N/A
|
(132)
+6%
|
(116)
+12%
|
(100)
+14%
|
(89)
+12%
|
(61)
+32%
|
(52)
+14%
|
(49)
+5%
|
|
Net Income | |||||||||
Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
|
Income from Continuing Operations |
(140)
|
(132)
|
(117)
|
(101)
|
(89)
|
(61)
|
(53)
|
(50)
|
|
Net Income (Common) |
(140)
N/A
|
(132)
+6%
|
(117)
+12%
|
(101)
+14%
|
(89)
+12%
|
(61)
+31%
|
(53)
+14%
|
(50)
+5%
|
|
EPS (Diluted) |
-58.98
N/A
|
-46.54
+21%
|
-27.13
+42%
|
-23.24
+14%
|
-22.52
+3%
|
-13.94
+38%
|
-12.14
+13%
|
-0.76
+94%
|